LYMPH NODE CANCER METASTATIC

This adverse event was reported 40 times

LYMPH NODE CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NISOLDIPINE 1 0.0008
1 MEPROBAMATE 1 0.0008
2 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 5 0.0002
3 TAMOXIFEN CITRATE 1 0.0002
4 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 2 0.0002
5 CALCIUM GLUCONATE 2 0.0002
6 METHYLPREDNISOLONE ACETATE 1 0.0001
7 CONJUGATED ESTROGENS 6 0.0001
8 ESTROGENS, CONJUGATED 6 0.0001
9 EXEMESTANE 2 0.0001
See all drugs enriched for association with LYMPH NODE CANCER METASTATIC

LYMPH NODE CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen [EPC] 7 0.0000
1 Aromatase Inhibitor [EPC] 4 0.0000
2 Provitamin D2 Compound [EPC] 1 0.0000
3 Estrogen Receptor Antagonist [EPC] 1 0.0000
4 Thiazide Diuretic [EPC] 5 0.0000
5 Insulin [EPC] 1 0.0000
6 Folate Analog [EPC] 1 0.0000
7 Vitamin A [EPC] 1 0.0000
8 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
9 Nicotinic Acid [EPC] 1 0.0000
See all drug classes enriched for association with LYMPH NODE CANCER METASTATIC